Toxicology of deoxynivalenol and its acetylated and modified forms
[1] Cardiovascular outcome trials have demonstrated safety and, for specific agents (liraglutide, injectable semaglutide, dulaglutide), cardiovascular benefit, making them preferred options for patients with established cardiovascular disease
The injuries most commonly at issue in current GLP-1 litigation include gastroparesis, intestinal obstruction, bowel injury, pancreatitis, gallbladder disease, and sudden vision loss caused by NAION
Moreover, they stress the pivotal connection between self-awareness and behavioral management rooted in childhood experiences
Together, they handle multi-medication travel effectively
People with type 2 diabetes and obesity experience higher rates of depression and anxiety compared to the general population